|
| |
| | | 57658 | | 02.02.2007 | | Bristol-Myers Squibb SA | | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Sprycel 20 mg | Filmtabletten | Coated tablets (Dasatinib 20 mg) | L01EA02 | CI | | 02 | Sprycel 50 mg | Filmtabletten | Coated tablets (Dasatinib 50 mg) | L01EA02 | CI | | 03 | Sprycel 70 mg | Filmtabletten | Coated tablets (Dasatinib 70 mg) | L01EA02 | CI | | 04 | Sprycel 100 mg | Filmtabletten | Coated tablets (Dasatinib 100 mg) | L01EA02 | CI | | 05 | Sprycel 80 mg | Filmtabletten | Coated tablets (Dasatinib 80 mg) | L01EA02 | CI | | 06 | Sprycel 140 mg | Filmtabletten | Coated tablets (Dasatinib 140 mg) | L01EA02 | CI |
|
|
|
